Atara Biotherapeutics, Inc. (ATRA) Financials
ATRA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 188.8 million | 239.6 million |
2023-06-30 | 246.4 million | 239.0 million |
2023-03-31 | 302.1 million | 237.1 million |
2022-12-31 | 376.4 million | 249.8 million |
ATRA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -51.6 million | 11.1 million |
2023-06-30 | -53.3 million | 12.6 million |
2023-03-31 | -38.8 million | 11.8 million |
2022-12-31 | -56.9 million | 11.4 million |
ATRA Net Income
No data available :(
ATRA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 102.4 million | - | 61.8 million |
2023-06-30 | 153.6 million | - | 64.7 million |
2023-03-31 | 205.4 million | - | 54.9 million |
2022-12-31 | 242.8 million | - | 71.7 million |
ATRA Shares Outstanding
ATRA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 281000 | 56.9 million | 12.2 million | - |
2023-06-30 | 499000 | 56.1 million | 13.3 million | - |
2023-03-31 | 399000 | 62.2 million | 13.9 million | - |
2022-12-31 | 37000 | 62.5 million | 13.2 million | - |
ATRA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 2.1 million | 2.6 million |
2023-06-30 | 957000 | 2.9 million |
2023-03-31 | 1.2 million | 216000 |
2022-12-31 | 221000 | 4.1 million |
ATRA
Price: $0.65
52 week price:
Earnings Per Share: -2.78 USD
P/E Ratio: -0.29
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 783100
Ebitda: -31.4 millionMarket Capitalization: 73.1 million